HYPD

Hyperion DeFi Inc. Common Stock (HYPD)

Stock · NASDAQ · Health Care

$2.87as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

Hyperion DeFi Launches Institutional Credit and Data Feed Deals. Hyperion DeFi announced the rollout of its first institutional credit facility on the Aviya Finance platform. The company also agreed to assist DoubleZero in deploying commercially available Hyperliquid data feeds. These moves signal a push toward broader institutional adoption and new revenue streams for the firm.

Active signals

Resistance level
$3.36
Industry
Biotechnology: Pharmaceutical Preparations

What HYPD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike24-20.7%25%
Bollinger Band Breakout18+5.1%56%
Bollinger Band BreakdownActive now17-7.7%35%
200-Day Moving Average TouchActive now3-24.3%0%
Any 20-session window (baseline)-7.7%38%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About HYPD

Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
9

Fundamentals

1-day range
$2.87$3.15
Market cap
$40.47M
P/E (trailing)
7.24
P/E (forward)
—
EPS (trailing)
$-2.10
Dividend yield
—
Beta
2.62
Avg. volume
464.9K
52-week range
$2.34$9.13
Next earnings: November 12, 2026 · EPS estimate $2.31confirmed

How Hyperion DeFi Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$813.5KSG&A$17.18M (2111%)R&D$1.91M (235%)Cost of Revenue$303.3K (37%)HYPD

Source: 10-K filed Mar 30, 2026 · via SEC EDGAR / Finnhub

Gross Profit$510.2K(63%)
Operating Income-$46.72M(-5744%)

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$11.2
+290.2%
Median
$9.83
+242.3%
Low
$8.45
+194.4%

Hyperion DeFi Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • HYPD
    Hyperion DeFi Inc. Common Stock
    $2.84
    ▼ 9.84%
    Market cap $40.47MP/E 7.24
    $2.34$9.13
  • RADX
    Radiopharm Theranostics Limited American Depositary Shares
    $1.03
    ▼ 4.63%
    Market cap $40.11MP/E —
    $0.0035$0.037
  • NSRX
    Nasus Pharma Ltd. Ordinary Shares
    $3.18
    ▲ 0.47%
    Market cap $39.70MP/E —
    $1.98$9.5
  • PDSB
    PDS Biotechnology Corporation Common Stock
    $1.13
    ▼ 13.08%
    Market cap $41.78MP/E —
    $0.1952$1.79
  • APLM
    Apollomics Inc. Class A Ordinary Shares
    $21.1
    ▲ 0.48%
    Market cap $37.33MP/E —
    $10.01$42.12
  • CRVO
    CervoMed Inc. Common Stock
    $2.24
    ▼ 0.44%
    Market cap $37.33MP/E —
    $2.13$10
  • IXHL
    Incannex Healthcare Inc. Common Stock
    $2.82
    ▼ 2.08%
    Market cap $37.21MP/E —
    $2.49$14.91

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
243.2K
Disposed
80.0K

Institutional Ownership

March 31, 2026

Total shares held
1.26M
Total value held
$4.26M
Institutional holders
27
Top holders this quarter
  • Unknown238.0K
  • Unknown183.3K
  • Unknown128.3K
  • Unknown115.6K
  • Unknown112.9K
  • Unknown81.1K
  • Unknown77.1K
  • Unknown64.3K
  • Unknown51.9K
  • Unknown48.8K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.